Exploring Hidden Risks: New Study Investigates Causes of Nonrelapse Deaths in Cancer Patients Undergoing CAR-T Treatments
Recent findings indicate a concerning trend among cancer patients undergoing CAR-T cell therapies, with a significant portion of deaths attributed to causes unrelated to cancer relapse. The study, which delved deep into patient outcomes, sheds light on the need for enhanced patient monitoring and support systems during treatment. CAR-T therapy, a breakthrough in the treatment of blood cancers, involves modifying a patient’s T-cells to better recognize and destroy cancer cells. While the treatment has been …